Disclosures under Regulation 62 of the SEBI Listing Regulations
Disclosures under Regulation 62 of the SEBI Listing Regulations
Scheme of Arrangement
General Policies
Other Informations
Disclosures under Regulation 62 of the SEBI Listing Regulations
Disclosures under Regulation 62 of the SEBI Listing Regulations
Disclosures under Regulation 62(1A), of the SEBI Listing Regulations
| Sl. No. | Particulars as per LODR |
|---|---|
| 1. | (a) composition of the various committees of the board of directors; |
| 2. | (b) terms and conditions of appointment of independent directors; |
| 3. | (c) code of conduct of the board of directors and senior management personnel; |
| 4. | (d) details of establishment of vigil mechanism/ whistle blower policy; |
| 5. | (e) criteria of making payments to non-executive directors, if the same has not been disclosed in the annual report; |
| 6. | (f) secretarial compliance report as per sub-regulation (2) of regulation 24A of these regulations; |
| 7. | (g) policy on dealing with related party transactions; debt securities; |
| 8. | (h) policy for determining ‘material’ subsidiaries; |
| 9. | (i) Details of familiarization programmes imparted to independent directors including the following details: (iii) other relevant details. |
Disclosures under Regulation 62 of the SEBI Listing Regulations
Disclosures under Regulation 62 of the SEBI Listing Regulations
Disclosures under Regulation 62(1A), of the SEBI Listing Regulations
| Sl. No. | Particulars as per LODR |
|---|---|
| 1. | (a) composition of the various committees of the board of directors; |
| 2. | (b) terms and conditions of appointment of independent directors; |
| 3. | (c) code of conduct of the board of directors and senior management personnel; |
| 4. | (d) details of establishment of vigil mechanism/ whistle blower policy; |
| 5. | (e) criteria of making payments to non-executive directors, if the same has not been disclosed in the annual report; |
| 6. | (f) secretarial compliance report as per sub-regulation (2) of regulation 24A of these regulations; |
| 7. | (g) policy on dealing with related party transactions; debt securities; |
| 8. | (h) policy for determining ‘material’ subsidiaries; |
| 9. | (i) Details of familiarization programmes imparted to independent directors including the following details: (iii) other relevant details. |
Scheme of Arrangement
Scheme of Arrangement
| Title | Categories | Download |
|---|---|---|
| Scheme of Amalgamation of Aquapharm Chemicals Private Limited with Advaya Chemical Industries Limited | SchemeofArrangement |  |
| Intimation of the 1st EGM Notice of Advaya Chemical Industries Limited relating to approval of the scheme of amalgamation of Aquapharm Chemicals Private Limited with Advaya Chemical Industries Limited and their respective shareholders | SchemeofArrangement | |
| Intimation of effectiveness of the Scheme of Amalgamation of Aquapharm Chemicals Private Limited with Advaya Chemical Industries Limited (“Company”) and their respective shareholders | SchemeofArrangement | |
| Disclosures under Regulation 51 for the Scheme of Amalgamation of Aquapharm Chemicals Private Limited with the Company” – Outcome of the Board Meeting held on 1st August, 2024 | SchemeofArrangement | |
| Intimation of receipt of certified copy of the final Order sanctioning the Scheme of Amalgamation of Aquapharm Chemicals Private Limited with Advaya Chemical Industries Limited and their respective shareholders under Section 233 and other applicable provisions of the Companies Act, 2013 (“Scheme”) | SchemeofArrangement | |
| Confirmation of Order of Scheme of Amalgamation between Aquapharm Chemicals Private Limited (Transferor Company) with Advaya Chemical Industries Limited (Transferee Company) in Form No. CAA 12 | SchemeofArrangement | |
General Policies
General Policies
Other Informations
▼ Compliance under Regulation 7(2) and 7(3)
▼ Compliance under Regulation 13(3)
▼ Compliance under Regulation 23 (9)
▼ Compliance under Regulation 24(A)
▼ Compliance under Regulation 27
▼ Compliance under Regulation 61(4)
▼ Compliance Under Regulation 50 (1)
▼ Compliance under Regulation 51
▼ Compliance under Regulations 52
▼ Compliance under Regulations 54
▼Compliance under Regulations 55
▼Compliance under Regulation 57
▼Compliance under Regulation 53
▼Compliance under Regulation 59A
Disclosures under Regulation 62 of the SEBI Listing Regulations
Scheme of Arrangement
General Policies
Other Informations
General Meetings
Disclosures under Regulation 62 of the SEBI Listing Regulations
Disclosures under Regulation 62 of the SEBI Listing Regulations
Disclosures under Regulation 62(1A), of the SEBI Listing Regulations
Scheme of Arrangement
Scheme of Arrangement
| Title | Categories | Download |
|---|---|---|
| Scheme of Amalgamation of Aquapharm Chemicals Private Limited with Advaya Chemical Industries Limited | SchemeofArrangement | |
| Intimation of the 1st EGM Notice of Advaya Chemical Industries Limited relating to approval of the scheme of amalgamation of Aquapharm Chemicals Private Limited with Advaya Chemical Industries Limited and their respective shareholders | SchemeofArrangement | |
| Intimation of effectiveness of the Scheme of Amalgamation of Aquapharm Chemicals Private Limited with Advaya Chemical Industries Limited (“Company”) and their respective shareholders | SchemeofArrangement | |
| Disclosures under Regulation 51 for the Scheme of Amalgamation of Aquapharm Chemicals Private Limited with the Company” – Outcome of the Board Meeting held on 1st August, 2024 | SchemeofArrangement | |
| Intimation of receipt of certified copy of the final Order sanctioning the Scheme of Amalgamation of Aquapharm Chemicals Private Limited with Advaya Chemical Industries Limited and their respective shareholders under Section 233 and other applicable provisions of the Companies Act, 2013 (“Scheme”) | SchemeofArrangement | |
| Confirmation of Order of Scheme of Amalgamation between Aquapharm Chemicals Private Limited (Transferor Company) with Advaya Chemical Industries Limited (Transferee Company) in Form No. CAA 12 | SchemeofArrangement | |
General Policies
General Policies
Other Informations
▼ Compliance under Regulation 7(2) and 7(3)
| Title | Categories | Download |
|---|---|---|
| Compliance under Regulation 7(2) and 7(3) | Compliance under Regulation 7(2) and 7(3) | |
Rows per page:
1–1 of 1
1–1 of 1
▼ Compliance under Regulation 13(3)
| Title | Categories | Download |
|---|---|---|
| Compliance under Regulation 13(3) for the quarter ended 31st March 2026 | Compliance under Regulation 13(3) | |
| Compliance under Regulation 13(3) for the quarter ended 31st December 2025 | Compliance under Regulation 13(3) | |
| Compliance under Regulation 13(3) for the quarter ended 30th September 2025 | Compliance under Regulation 13(3) | |
| Compliance under Regulation 13(3) for the quarter ended June 2025 | Compliance under Regulation 13(3) | |
| Compliance under Regulation 13(3) for the quarter ended March 2025 | Compliance under Regulation 13(3) | |
| Compliance under Regulation 13(3) for the quarter ended December, 2024 | Compliance under Regulation 13(3) | |
| Compliance under Regulation 13(3) for the quarter ended September, 2024 | Compliance under Regulation 13(3) | |
Rows per page:
1–3 of 3
1–3 of 3
▼ Compliance under Regulation 23 (9)
| Title | Categories | Download |
|---|---|---|
| Related Party Transactions under Regulation 23(9) for the half year ended 30th September 2025 | Compliance under Regulation 23 (9) | |
| Related Party Transactions under Regulation 23(9) for the half year ended 31st March, 2025 | Compliance under Regulation 23 (9) | |
Rows per page:
1–1 of 1
1–1 of 1
▼ Compliance under Regulation 24(A)
| Title | Categories | Download |
|---|---|---|
| Annual Secretarial Compliance Report for the financial year ended 31st March, 2025 | Compliance under Regulation 24(A) | |
Rows per page:
1–1 of 1
1–1 of 1
▼ Compliance under Regulation 27
| Title | Categories | Download |
|---|---|---|
| Compliance Report on Corporate Governance for the quarter and year ended 31st March 2026 | Compliance under Regulation 27 | |
| Compliance Report on Corporate Governance for the quarter ended 31st December 2025 | Compliance under Regulation 27 | |
| Compliance Report on Corporate Governance for the quarter and half year ended 30th September 2025 | Compliance under Regulation 27 | |
| Compliance Report on Corporate Governance for the quarter ended 30th June 2025 | Compliance under Regulation 27 | |
| Compliance Report on Corporate Governance for the quarter and year ended 31st March 2025 | Compliance under Regulation 27 | |
| Compliance Report on Corporate Governance for the quarter and half year ended 30th September, 2024 | Compliance under Regulation 27 | |
Rows per page:
1–2 of 2
1–2 of 2
▼ Compliance under Regulation 61(4)
No documents available under Regulation 61(4) currently.
▼ Compliance Under Regulation 50 (1)
| Title | Categories | Download |
|---|---|---|
| Intimation of Board Meeting dated 23rd April 2026 under Regulation 50(1)(c) | Compliance under Regulation 50 (1) | |
| Intimation of Board Meeting dated 9th March 2026 under Regulation 50(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 | Compliance under Regulation 50 (1) | |
| Intimation of Board Meeting dated 12th January 2026 under Regulation 50(1)(c) | Compliance Under Regulation 50 (1) | |
| Intimation of Board Meeting dated 10th October 2025 under Regulation 50(1)(c) | Compliance Under Regulation 50 (1) | |
| Intimation of Board Meeting dated 23rd July 2025 under Regulation 50(1)(c) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 | Compliance Under Regulation 50 (1) | |
| Update on agenda of Board Meeting to be held on Monday, the 14th day of July 2025 | Compliance Under Regulation 50 (1) | |
| Postponement of Board Meeting scheduled on Thursday, the 10th day of July 2025 to Monday, the 14th day of July 2025 | Compliance Under Regulation 50 (1) | |
| Intimation of Board Meeting dated 10th July 2025 under Regulation 50(1)(c) | Compliance Under Regulation 50 (1) | |
| Intimation of Board Meeting dated 23 April 2025 under Regulation 50(1)(c) | Compliance Under Regulation 50 (1) | |
Rows per page:
1–1 of 1
1–1 of 1
▼ Compliance Under Regulation 51
| Title | Categories | Download |
|---|---|---|
| Intimation of Newspaper Publication of Extract of Audited Consolidated Financial Results of the Company for the quarter and year ended 31st March 2026. | Compliance under Regulation 51 | |
| Intimation of Newspaper Publication of Extract of Un-Audited Consolidated Financial Results of the Company for the quarter ended 31st December 2025. | Compliance under Regulation 51 | |
| Intimation of Newspaper Publication of Extract of Un-audited Consolidated Financial Results of the Company for the quarter and half-year ended 30th September 2025. | Compliance under Regulation 51 | |
| Submission of details of listed ISIN of Aquapharm Chemical Limited for the half year ended 30th September 2025 – Half Yearly Reporting as per Chapter VIII of the SEBI Master Circular dated 22nd May 2024 | Compliance under Regulation 51 | |
| Intimation of appointment of Dr. Somil Mehta has been appointed as the Senior Vice President – Global R & D and Head, Innovation Centre of the Company. | Compliance under Regulation 51 | |
| Intimation of Newspaper Publication of Extract of Audited Consolidated Financial Results of the Company for the quarter and financial year ended 31st March 2025. | Compliance under Regulation 51 | |
| Submission of details of listed ISIN of Aquapharm Chemical Limited for the half year ended 31st March 2025 – Half Yearly Reporting as per Chapter VIII of the SEBI Master Circular dated 22nd May 2024 | Compliance under Regulation 51 | |
| Intimation under Regulation 51 read with Part B of Schedule III of SEBI Listing Regulations – Appointment of Mr. Suresh Kalra as an Additional Director and Whole-time Director, Mr. Kaushik Roy, as an Additional Director and cessation of Mr. Kaushik Mukherjee, as a Whole-time Director & Mr. Raj Kumar Gupta, as a Director | Compliance under Regulation 51 | |
| Intimation of the 2nd EGM Notice of Aquapharm Chemical Limited (formerly known as Advaya Chemical Industries Limited) relating to Appointment of Ms. Iram Hassan as a Director (Non-Executive Independent Director) and Mr. Gopal Rathi (DIN: 00553066) as a Director (Non-Executive Director) of the Company | Compliance under Regulation 51 | |
| Intimation under Regulation 51 read with Part B of Schedule III of SEBI Listing Regulations – Appointment of Mr. Suresh Kalra, as the Chief Executive Officer, KMP of the Company. | Compliance under Regulation 51 | |
| Intimation under Regulation 51 read with Part B of Schedule III of SEBI Listing Regulations – Allotment of equity shares of Advaya Chemical Industries Limited (subsidiary of PCBL Chemical Limited) pursuant to conversion of unlisted optionally and fully convertible debentures | Compliance under Regulation 51 | |
| Intimation under Regulation 51 read with Part B of Schedule III of SEBI Listing Regulations – Resignation of CS and CFO (KMPs) and Appointment of CS and CFO in place of resigning KMPs. | Compliance under Regulation 51 | |
| Intimation of the Newspaper Publication of the Extract of Unaudited Consolidated Financial Results for the quarter and nine months ended 31st December, 2024 | Compliance under Regulation 51 | |
| Intimation under Regulation 51(2) of the SEBI Listing Regulations read with Part B of Schedule III – Appointment of Mr. Gopal Rathi and Ms. Iram Hassan | Compliance under Regulation 51 | |
| Disclosures under Regulation 51 for Scheme of Amalgamation of Aquapharm Chemicals Private Limited with the Company | Compliance under Regulation 51 | |
| Appt of IDs, Cessation of GR and Shifting of RO | Compliance under Regulation 51 | |
| Fine levied under Reg 6 | Compliance under Regulation 51 | |
| Fine levied under Reg 6 (Reply) | Compliance under Regulation 51 | |
| Appt of CS | Compliance under Regulation 51 | |
| Appt of CFO & WTD | Compliance under Regulation 51 | |
| Submission of details of listed ISIN of Advaya Chemical Industries Limited for the half year ended 30th September, 2024 – Half Yearly Reporting as per Chapter VIII of the SEBI Master Circular dated 22nd May, 2024 | Compliance under Regulation 51 | |
| Intimation of the 1st EGM Notice of Advaya Chemical Industries Limited relating to approval of the scheme of amalgamation of Aquapharm Chemicals Private Limited with Advaya Chemical Industries Limited and their respective shareholders | Compliance under Regulation 51 | |
| Intimation of proceedings of the 1st EGM of Advaya Chemical Industries Limited | Compliance under Regulation 51 | |
| Intimation of Newspaper Publication of the Extract of Unaudited Consolidated Financial Results for the quarter and half year ended 30th September, 2024 | Compliance under Regulation 51 | |
| Intimation pursuant to Regulation 51 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015 (“SEBI Listing Regulations”) read with Part B of Schedule III of SEBI Listing Regulations – Change in Auditor (Resignation of Statutory Auditor) | Compliance under Regulation 51 | |
Rows per page:
1–5 of 22
1–5 of 22
▼ Compliance under Regulations 52
| Title | Categories | Download |
|---|---|---|
| Financial Results (Standalone & Consolidated) for the quarter and year ended 31st March 2026 | Compliance under Regulations 52 | |
| Financial Results (Standalone & Consolidated) for the quarter ended 31st December 2025 | Compliance under Regulations 52 | |
| Financial Results for the quarter and half-year ended 30th September 2025 | Compliance under Regulations 52 | |
| Financial Results for the quarter and year ended 31st March 2025 | Compliance under Regulations 52 | |
| Financial Results for the quarter and nine months ended 31st December, 2024 | Compliance under Regulations 52 | |
| Financials (31-03-2024) | Compliance under Regulations 52 | |
| Statement of Utilization of Issue Proceeds of NCD | Compliance under Regulations 52 | |
| Financials (30-06-2024) | Compliance under Regulations 52 | |
| Financials (30-09-2024) | Compliance under Regulations 52 | |
Rows per page:
1–6 of 6
1–6 of 6
▼ Compliance under Regulations 54
| Title | Categories | Download |
|---|---|---|
| Asset Cover Details (31-03-2026) | Compliance under Regulations 54 | |
| Asset Cover Details (31-12-2025) | Compliance under Regulations 54 | |
| Asset Cover Details (30-09-2025) | Compliance under Regulations 54 | |
| Asset Cover Details (30-06-2025) | Compliance under Regulations 54 | |
| Asset Cover Details (31-03-2025) | Compliance under Regulations 54 | |
| Asset Cover Details (31-12-2024) | Compliance under Regulations 54 | |
| Asset Cover Details (31-03-2024) | Compliance under Regulations 54 | |
| Asset Cover Details (30-06-2024) | Compliance under Regulations 54 | |
| Asset Cover Details (30-09-2024) | Compliance under Regulations 54 | |
Rows per page:
1–3 of 3
1–3 of 3
▼Compliance under Regulations 55
| Title | Categories | Download |
|---|---|---|
| Credit Rating – Aquapharm Chemical Limited (formerly known as Advaya Chemical Industries Limited) – Rs. 550 Crore – Non-convertible Debentures – 2026. | Compliance under Regulations 55 | |
| Credit Rating – Aquapharm Chemical Limited (formerly known as Advaya Chemical Industries Limited) – Bank Facilities – 2026. | Compliance under Regulations 55 | |
| Credit Rating – Advaya Chemical Industries Limited – Rs. 550 Crore – Non-convertible Debentures – 2025. | Compliance under Regulations 55 | |
| Credit Rating – Advaya Chemical Industries Limited – Bank Facilities – 2025. | Compliance under Regulations 55 | |
| Credit Rating – Advaya Chemical Industries Limited – Rs. 550 Crore – Non-convertible Debentures – 2024. | Compliance under Regulations 55 | |
| Credit Rating – Advaya Chemical Industries Limited – Bank Facilities – 2024. | Compliance under Regulations 55 | |
Rows per page:
1–3 of 3
1–3 of 3
▼Compliance under Regulation 57
| Title | Categories | Download |
|---|---|---|
| Intimation of annual interest payment under Regulation 57 of the SEBI Listing Regulations – Advaya | Compliance under Regulation 57 | |
| Compliances-Reg. 57 (1) – Certificate of interest payment/Principal in case of NCD – 29-01-2026 | Compliance under Regulation 57 | |
Rows per page:
1–1 of 1
1–1 of 1
▼Compliance under Regulation 53
| Title | Categories | Download |
|---|---|---|
| Annual Report – FY 2023-24 | Compliance under Regulation 53 | |
| Newspaper Advertisement – Publication of the Notice of the 1st Annual General Meeting and Book Closure Notice for the financial year ended 31st March, 2024 | Compliance under Regulation 53 | |
| Financial Statements of Aquapharm Chemicals Private Limited | Compliance under Regulation 53 | |
| Draft Annual Return in Form MGT-7 for the FY 23-24 | Compliance under Regulation 53 | |
| Submission of the summary of the Proceedings of the 1st Annual General Meeting of the Members of the Company | Compliance under Regulation 53 | |
Rows per page:
1–5 of 5
1–5 of 5
▼Compliance under Regulation 59A
| Title | Categories | Download |
|---|---|---|
| Amalgamation Notice | Compliance under Regulation 59A | |
Rows per page:
1–1 of 1
1–1 of 1
General Meetings
General Meetings
AGM – 2025
Recording of the proceedings of the 63rd AGM:
| Title | Categories | Download |
|---|---|---|
| Aquapharm Chemical Limited – Annual Report 2024-25 | AGM – 2025 , General Meeting | |
Disclosures under Regulation 62 of the SEBI Listing Regulations
Scheme of Arrangement
General Policies
Other Informations
General Meetings
Disclosures under Regulation 62 of the SEBI Listing Regulations
Disclosures under Regulation 62 of the SEBI Listing Regulations
Disclosures under Regulation 62(1A), of the SEBI Listing Regulations
| Sl. No. | Particulars as per LODR |
|---|---|
| (a) | composition of the various committees of the board of directors; |
| (b) | terms and conditions of appointment of independent directors; |
| (c) | code of conduct of the board of directors and senior management personnel; |
| (d) | details of establishment of vigil mechanism/ whistle blower policy; |
| (e) | criteria of making payments to non-executive directors, if the same has not been disclosed in the annual report; |
| (f) | secretarial compliance report as per sub-regulation (2) of regulation 24A of these regulations; |
| (g) | policy on dealing with related party transactions; debt securities; |
| (h) | policy for determining ‘material’ subsidiaries; |
| (i) | Details of familiarization programmes imparted to independent directors including the following details: (iii) other relevant details. |
Scheme of Arrangement
Scheme of Arrangement
| Title | Categories | Download |
|---|---|---|
| Scheme of Amalgamation of Aquapharm Chemicals Private Limited with Advaya Chemical Industries Limited | SchemeofArrangement | |
| Intimation of the 1st EGM Notice of Advaya Chemical Industries Limited relating to approval of the scheme of amalgamation of Aquapharm Chemicals Private Limited with Advaya Chemical Industries Limited and their respective shareholders | SchemeofArrangement | |
| Intimation of effectiveness of the Scheme of Amalgamation of Aquapharm Chemicals Private Limited with Advaya Chemical Industries Limited (“Company”) and their respective shareholders | SchemeofArrangement | |
| Disclosures under Regulation 51 for the Scheme of Amalgamation of Aquapharm Chemicals Private Limited with the Company” – Outcome of the Board Meeting held on 1st August, 2024 | SchemeofArrangement | |
| Intimation of receipt of certified copy of the final Order sanctioning the Scheme of Amalgamation of Aquapharm Chemicals Private Limited with Advaya Chemical Industries Limited and their respective shareholders under Section 233 and other applicable provisions of the Companies Act, 2013 (“Scheme”) | SchemeofArrangement | |
| Confirmation of Order of Scheme of Amalgamation between Aquapharm Chemicals Private Limited (Transferor Company) with Advaya Chemical Industries Limited (Transferee Company) in Form No. CAA 12 | SchemeofArrangement | |
General Policies
General Policies
Board Diversity Policy
DOWNLOAD
Policy on Preservation of Documents
DOWNLOAD
Remuneration Policy
DOWNLOAD
Risk Management Policy
DOWNLOAD
Succession Planning Policy for the Board & Senior Management
DOWNLOAD
Code of Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons and Immediate Relatives of Designated Persons, and Legitimate Purpose Policy
DOWNLOAD
Other Informations
▼ Compliance under Regulation 7(2) and 7(3)
| Title | Categories | Download |
|---|---|---|
| Compliance under Regulation 7(2) and 7(3) | Compliance under Regulation 7(2) and 7(3) | |
Rows per page:
1–1 of 1
1–1 of 1
▼ Compliance under Regulation 13(3)
| Title | Categories | Download |
|---|---|---|
| Compliance under Regulation 13(3) for the quarter ended 30th June 2026 | Compliance under Regulation 13(3) | |
| Compliance under Regulation 13(3) for the quarter ended 31st March 2026 | Compliance under Regulation 13(3) | |
| Compliance under Regulation 13(3) for the quarter ended 31st December 2025 | Compliance under Regulation 13(3) | |
| Compliance under Regulation 13(3) for the quarter ended 30th September 2025 | Compliance under Regulation 13(3) | |
| Compliance under Regulation 13(3) for the quarter ended June 2025 | Compliance under Regulation 13(3) | |
| Compliance under Regulation 13(3) for the quarter ended March 2025 | Compliance under Regulation 13(3) | |
| Compliance under Regulation 13(3) for the quarter ended December, 2024 | Compliance under Regulation 13(3) | |
| Compliance under Regulation 13(3) for the quarter ended September, 2024 | Compliance under Regulation 13(3) | |
Rows per page:
1–3 of 3
1–3 of 3
▼ Compliance under Regulation 23 (9)
| Title | Categories | Download |
|---|---|---|
| Related Party Transactions under Regulation 23(9) for the half year ended 31st March 2026 | Compliance under Regulation 23 (9) | |
| Related Party Transactions under Regulation 23(9) for the half year ended 30th September 2025 | Compliance under Regulation 23 (9) | |
| Related Party Transactions under Regulation 23(9) for the half year ended 31st March, 2025 | Compliance under Regulation 23 (9) | |
Rows per page:
1–1 of 1
1–1 of 1
▼ Compliance under Regulation 24(A)
| Title | Categories | Download |
|---|---|---|
| Annual Secretarial Compliance Report for the financial year ended 31st March, 2025 | Compliance under Regulation 24(A) | |
| Annual Secretarial Compliance Report for the financial year ended 31st March, 2026 | Compliance under Regulation 24(A) | |
Rows per page:
1–1 of 1
1–1 of 1
▼ Compliance under Regulation 27
| Title | Categories | Download |
|---|---|---|
| Compliance Report on Corporate Governance for the quarter and year ended 30th June 2026. | Compliance under Regulation 27 | |
| Compliance Report on Corporate Governance for the quarter and year ended 31st March 2026 | Compliance under Regulation 27 | |
| Compliance Report on Corporate Governance for the quarter ended 31st December 2025 | Compliance under Regulation 27 | |
| Compliance Report on Corporate Governance for the quarter and half year ended 30th September 2025 | Compliance under Regulation 27 | |
| Compliance Report on Corporate Governance for the quarter ended 30th June 2025 | Compliance under Regulation 27 | |
| Compliance Report on Corporate Governance for the quarter and year ended 31st March 2025 | Compliance under Regulation 27 | |
| Compliance Report on Corporate Governance for the quarter ended 31st December 2024 | Compliance under Regulation 27 | |
| Compliance Report on Corporate Governance for the quarter and half year ended 30th September, 2024 | Compliance under Regulation 27 | |
| Compliance Report on Corporate Governance for the quarter ended 30th June 2024 | Compliance under Regulation 27 | |
Rows per page:
1–2 of 2
1–2 of 2
▼ Compliance Under Regulation 50 (1)
| Title | Categories | Download |
|---|---|---|
| Intimation of Board Meeting dated 23rd April 2026 | Compliance under Regulation 50 (1) | |
| Intimation of Board Meeting dated 9th March 2026 | Compliance under Regulation 50 (1) | |
| Intimation of Board Meeting dated 12th January 2026 | Compliance Under Regulation 50 (1) | |
| Intimation of Board Meeting dated 10th October 2025 | Compliance Under Regulation 50 (1) | |
| Intimation of Board Meeting dated 23rd July 2025 | Compliance Under Regulation 50 (1) | |
| Update on agenda of Board Meeting to be held on Monday, the 14th day of July 2025 | Compliance Under Regulation 50 (1) | |
| Postponement of Board Meeting scheduled on Thursday, the 10th day of July 2025 to Monday, the 14th day of July 2025 | Compliance Under Regulation 50 (1) | |
| Intimation of Board Meeting dated 10th July 2025 | Compliance Under Regulation 50 (1) | |
| Intimation of Board Meeting dated 23 April 2025 | Compliance Under Regulation 50 (1) | |
| Intimation of Board Meeting dated 7 January 2025 | Compliance Under Regulation 50 (1) | |
| Intimation of Board Meeting dated 23 October 2024 | Compliance Under Regulation 50 (1) | |
| Intimation of Board Meeting dated 17 July 2024 | Compliance Under Regulation 50 (1) | |
| Intimation of Board Meeting dated 22 May 2024 | Compliance Under Regulation 50 (1) | |
Rows per page:
1-1 of 1
1-1 of 1
▼ Compliance Under Regulation 51
| Title | Categories | Download |
|---|---|---|
| Intimation of proceedings of the 3rd Annual General Meeting of Aquapharm Chemical Limited (formerly known as Advaya Chemical Industries Limited). | Compliance under Regulation 51 | |
| Intimation of proceedings of the 01/2026-27 Extra-Ordinary General Meeting of Aquapharm Chemical Limited (formerly known as Advaya Chemical Industries Limited). | Compliance under Regulation 51 | |
| Intimation of Newspaper Publication of Extract of Audited Consolidated Financial Results of the Company for the quarter and year ended 31st March 2026. | Compliance under Regulation 51 | |
| Intimation of Newspaper Publication of Extract of Un-Audited Consolidated Financial Results of the Company for the quarter ended 31st December 2025. | Compliance under Regulation 51 | |
| Intimation of Newspaper Publication of Extract of Un-audited Consolidated Financial Results of the Company for the quarter and half-year ended 30th September 2025. | Compliance under Regulation 51 | |
| Submission of details of listed ISIN of Aquapharm Chemical Limited for the half year ended 30th September 2025 – Half Yearly Reporting as per Chapter VIII of the SEBI Master Circular dated 22nd May 2024 | Compliance under Regulation 51 | |
| Intimation of appointment of Dr. Somil Mehta has been appointed as the Senior Vice President – Global R & D and Head, Innovation Centre of the Company. | Compliance under Regulation 51 | |
| Intimation of Newspaper Publication of Extract of Audited Consolidated Financial Results of the Company for the quarter and financial year ended 31st March 2025. | Compliance under Regulation 51 | |
| Submission of details of listed ISIN of Aquapharm Chemical Limited for the half year ended 31st March 2025 – Half Yearly Reporting as per Chapter VIII of the SEBI Master Circular dated 22nd May 2024 | Compliance under Regulation 51 | |
| Intimation under Regulation 51 read with Part B of Schedule III of SEBI Listing Regulations – Appointment of Mr. Suresh Kalra as an Additional Director and Whole-time Director, Mr. Kaushik Roy, as an Additional Director and cessation of Mr. Kaushik Mukherjee, as a Whole-time Director & Mr. Raj Kumar Gupta, as a Director | Compliance under Regulation 51 | |
| Intimation of the 2nd EGM Notice of Aquapharm Chemical Limited (formerly known as Advaya Chemical Industries Limited) relating to Appointment of Ms. Iram Hassan as a Director (Non-Executive Independent Director) and Mr. Gopal Rathi (DIN: 00553066) as a Director (Non-Executive Director) of the Company | Compliance under Regulation 51 | |
| Intimation under Regulation 51 read with Part B of Schedule III of SEBI Listing Regulations – Appointment of Mr. Suresh Kalra, as the Chief Executive Officer, KMP of the Company. | Compliance under Regulation 51 | |
| Intimation under Regulation 51 read with Part B of Schedule III of SEBI Listing Regulations – Allotment of equity shares of Advaya Chemical Industries Limited (subsidiary of PCBL Chemical Limited) pursuant to conversion of unlisted optionally and fully convertible debentures | Compliance under Regulation 51 | |
| Intimation under Regulation 51 read with Part B of Schedule III of SEBI Listing Regulations – Resignation of CS and CFO (KMPs) and Appointment of CS and CFO in place of resigning KMPs. | Compliance under Regulation 51 | |
| Intimation of the Newspaper Publication of the Extract of Unaudited Consolidated Financial Results for the quarter and nine months ended 31st December, 2024 | Compliance under Regulation 51 | |
| Intimation under Regulation 51(2) of the SEBI Listing Regulations read with Part B of Schedule III – Appointment of Mr. Gopal Rathi and Ms. Iram Hassan | Compliance under Regulation 51 | |
| Disclosures under Regulation 51 for Scheme of Amalgamation of Aquapharm Chemicals Private Limited with the Company | Compliance under Regulation 51 | |
| Appt of IDs, Cessation of GR and Shifting of RO | Compliance under Regulation 51 | |
| Fine levied under Reg 6 | Compliance under Regulation 51 | |
| Fine levied under Reg 6 (Reply) | Compliance under Regulation 51 | |
| Appt of CS | Compliance under Regulation 51 | |
| Appt of CFO & WTD | Compliance under Regulation 51 | |
| Submission of details of listed ISIN of Advaya Chemical Industries Limited for the half year ended 30th September, 2024 – Half Yearly Reporting as per Chapter VIII of the SEBI Master Circular dated 22nd May, 2024 | Compliance under Regulation 51 | |
| Intimation of the 1st EGM Notice of Advaya Chemical Industries Limited relating to approval of the scheme of amalgamation of Aquapharm Chemicals Private Limited with Advaya Chemical Industries Limited and their respective shareholders | Compliance under Regulation 51 | |
| Intimation of proceedings of the 1st EGM of Advaya Chemical Industries Limited | Compliance under Regulation 51 | |
| Intimation of Newspaper Publication of the Extract of Unaudited Consolidated Financial Results for the quarter and half year ended 30th September, 2024 | Compliance under Regulation 51 | |
| Intimation pursuant to Regulation 51 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015 (“SEBI Listing Regulations”) read with Part B of Schedule III of SEBI Listing Regulations – Change in Auditor (Resignation of Statutory Auditor) | Compliance under Regulation 51 | |
Rows per page:
1–5 of 22
1–5 of 22
▼ Compliance under Regulations 52
| Title | Categories | Download |
|---|---|---|
| Financial Results (Standalone & Consolidated) for the quarter and year ended 30th June 2026 | Compliance under Regulations 52 | |
| Financial Results (Standalone & Consolidated) for the quarter and year ended 31st March 2026 | Compliance under Regulations 52 | |
| Financial Results (Standalone & Consolidated) for the quarter ended 31st December 2025 | Compliance under Regulations 52 | |
| Financial Results for the quarter and half-year ended 30th September 2025 | Compliance under Regulations 52 | |
| Financial Results for the quarter and year ended 31st March 2025 | Compliance under Regulations 52 | |
| Financial Results for the quarter and nine months ended 31st December, 2024 | Compliance under Regulations 52 | |
| Financials (30-09-2024) | Compliance under Regulations 52 | |
| Financials (30-06-2024) | Compliance under Regulations 52 | |
| Statement of Utilization of Issue Proceeds of NCD | Compliance under Regulations 52 | |
| Financials (31-03-2024) | Compliance under Regulations 52 | |
Rows per page:
1-6 of 6
1-6 of 6
▼Compliance under Regulation 53
| Title | Categories | Download |
|---|---|---|
| Annual Report – FY 2025-26 | Compliance under Regulation 53 | |
| Annual Report – FY 2024-25 | Compliance under Regulation 53 | |
| Annual Report – FY 2023-24 | Compliance under Regulation 53 | |
| Financial Statements of Aquapharm Chemicals Private Limited | Compliance under Regulation 53 | |
| Draft Annual Return in Form MGT-7 for the FY 23-24 | Compliance under Regulation 53 | |
| Submission of the summary of the Proceedings of the 1st Annual General Meeting of the Members of the Company | Compliance under Regulation 53 | |
| Newspaper Advertisement – Publication of the Notice of the 1st Annual General Meeting and Book Closure Notice for the financial year ended 31st March, 2024 | Compliance under Regulation 53 | |
| Financial Statements of Aquapharm Chemical Limited (formerly known as Advaya Chemical Industries Limited) | Compliance under Regulation 53 | |
| Draft Annual Return in Form MGT-7 for the FY 25-26 | Compliance under Regulation 53 | |
| Draft Annual Return in Form MGT-7 for the FY 24-25 | Compliance under Regulation 53 | |
| Submission of the summary of the Proceedings of the 1st Annual General Meeting of the Members of the Company | Compliance under Regulation 53 | |
Rows per page:
1–5 of 5
1–5 of 5
▼ Compliance under Regulations 54
Asset Cover Details (31-03-2024)Compliance under Regulations 54
| Title | Categories | Download |
|---|---|---|
| Asset Cover Details (30-06-2026) | Compliance under Regulations 54 | |
| Asset Cover Details (31-03-2026) | Compliance under Regulations 54 | |
| Asset Cover Details (31-12-2025) | Compliance under Regulations 54 | |
| Asset Cover Details (30-09-2025) | Compliance under Regulations 54 | |
| Asset Cover Details (30-06-2025) | Compliance under Regulations 54 | |
| Asset Cover Details (31-03-2025) | Compliance under Regulations 54 | |
| Asset Cover Details (31-12-2024) | Compliance under Regulations 54 | |
| Asset Cover Details (30-09-2024) | Compliance under Regulations 54 | |
| Asset Cover Details (30-06-2024) | Compliance under Regulations 54 | |
Rows per page:
1–3 of 3
1–3 of 3
▼Compliance under Regulations 55
| Title | Categories | Download |
|---|---|---|
| Credit Rating – Non-Convertible Debentures (NCDs) – 9th January 2026 | Compliance under Regulations 55 | |
| Credit Rating – Bank Facilities – 9th January 2026 | Compliance under Regulations 55 | |
| Credit Rating – Non-Convertible Debentures (NCDs) – 3rd March 2025 | Compliance under Regulations 55 | |
| Credit Rating – Bank Facilities – 3rd March 2025 | Compliance under Regulations 55 | |
| Credit Rating – Non-Convertible Debentures (NCDs) – 15 January 2024 | Compliance under Regulations 55 | |
| Credit Rating – Bank Facilities – 15 January 2024 | Compliance under Regulations 55 | |
Rows per page:
1–3 of 3
1–3 of 3
▼Compliance under Regulation 57
| Title | Categories | Download |
|---|---|---|
| Intimation of annual interest payment under Regulation 57 of the SEBI Listing Regulations – Advaya – 2025 | Compliance under Regulation 57 | |
| Intimation of annual interest payment under Regulation 57 of the SEBI Listing Regulations – ACL – 2026 | Compliance under Regulation 57 | |
Rows per page:
1–1 of 1
1–1 of 1
▼Compliance under Regulation 59A
| Title | Categories | Download |
|---|---|---|
| Amalgamation Notice | Compliance under Regulation 59A | |
Rows per page:
1–1 of 1
1–1 of 1
▼ Compliance under Regulation 61(4)
No documents available under Regulation 61(4) currently.
General Meetings
General Meetings
AGM – 2025
Recording of the proceedings of the AGM:| Title | Categories | Download |
|---|---|---|
| Aquapharm Chemical Limited – Annual Report 2024-25 | AGM – 2025 , General Meeting |
|
EGM – 29.06.2026
| Title | Categories | Download |
|---|---|---|
| Shorter Notice of the 01/2026-27 Extra Ordinary General Meeting – Monday, 29th June 2026 | EGM – 29.06.2026 |
|
AGM – 2026
| Title | Categories | Download |
|---|---|---|
| Aquapharm Chemical Limited – Annual Report 2025-26 | AGM – 2026 , General Meeting |
|
Disclosures under Regulation 62 of the SEBI Listing Regulations
Scheme of Arrangement
General Policies
Other Informations
General Meetings
Disclosures under Regulation 62 of the SEBI Listing Regulations
Disclosures under Regulation 62 of the SEBI Listing Regulations
Disclosures under Regulation 62(1A), of the SEBI Listing Regulations
| Sl. No. | Particulars as per LODR |
|---|---|
| (a) | composition of the various committees of the board of directors; |
| (b) | terms and conditions of appointment of independent directors; |
| (c) | code of conduct of the board of directors and senior management personnel; |
| (d) | details of establishment of vigil mechanism/ whistle blower policy; |
| (e) | criteria of making payments to non-executive directors, if the same has not been disclosed in the annual report; |
| (f) | secretarial compliance report as per sub-regulation (2) of regulation 24A of these regulations; |
| (g) | policy on dealing with related party transactions; debt securities; |
| (h) | policy for determining ‘material’ subsidiaries; |
| (i) | Details of familiarization programmes imparted to independent directors including the following details: (iii) other relevant details. |
Scheme of Arrangement
Scheme of Arrangement
| Title | Categories | Download |
|---|---|---|
| Scheme of Amalgamation of Aquapharm Chemicals Private Limited with Advaya Chemical Industries Limited | SchemeofArrangement | |
| Intimation of the 1st EGM Notice of Advaya Chemical Industries Limited relating to approval of the scheme of amalgamation of Aquapharm Chemicals Private Limited with Advaya Chemical Industries Limited and their respective shareholders | SchemeofArrangement | |
| Intimation of effectiveness of the Scheme of Amalgamation of Aquapharm Chemicals Private Limited with Advaya Chemical Industries Limited (“Company”) and their respective shareholders | SchemeofArrangement | |
| Disclosures under Regulation 51 for the Scheme of Amalgamation of Aquapharm Chemicals Private Limited with the Company” – Outcome of the Board Meeting held on 1st August, 2024 | SchemeofArrangement | |
| Intimation of receipt of certified copy of the final Order sanctioning the Scheme of Amalgamation of Aquapharm Chemicals Private Limited with Advaya Chemical Industries Limited and their respective shareholders under Section 233 and other applicable provisions of the Companies Act, 2013 (“Scheme”) | SchemeofArrangement | |
| Confirmation of Order of Scheme of Amalgamation between Aquapharm Chemicals Private Limited (Transferor Company) with Advaya Chemical Industries Limited (Transferee Company) in Form No. CAA 12 | SchemeofArrangement | |
General Policies
General Policies
Board Diversity Policy
DOWNLOAD
Policy on Preservation of Documents
DOWNLOAD
Remuneration Policy
DOWNLOAD
Risk Management Policy
DOWNLOAD
Succession Planning Policy for the Board & Senior Management
DOWNLOAD
Code of Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons and Immediate Relatives of Designated Persons, and Legitimate Purpose Policy
DOWNLOAD
Other Informations
▼ Compliance under Regulation 7(2) and 7(3)
| Title | Categories | Download |
|---|---|---|
| Compliance under Regulation 7(2) and 7(3) | Compliance under Regulation 7(2) and 7(3) | |
Rows per page:
1–1 of 1
1–1 of 1
▼ Compliance under Regulation 13(3)
| Title | Categories | Download |
|---|---|---|
| Compliance under Regulation 13(3) for the quarter ended 30th June 2026 | Compliance under Regulation 13(3) | |
| Compliance under Regulation 13(3) for the quarter ended 31st March 2026 | Compliance under Regulation 13(3) | |
| Compliance under Regulation 13(3) for the quarter ended 31st December 2025 | Compliance under Regulation 13(3) | |
| Compliance under Regulation 13(3) for the quarter ended 30th September 2025 | Compliance under Regulation 13(3) | |
| Compliance under Regulation 13(3) for the quarter ended June 2025 | Compliance under Regulation 13(3) | |
| Compliance under Regulation 13(3) for the quarter ended March 2025 | Compliance under Regulation 13(3) | |
| Compliance under Regulation 13(3) for the quarter ended December, 2024 | Compliance under Regulation 13(3) | |
| Compliance under Regulation 13(3) for the quarter ended September, 2024 | Compliance under Regulation 13(3) | |
Rows per page:
1–3 of 3
1–3 of 3
▼ Compliance under Regulation 23 (9)
| Title | Categories | Download |
|---|---|---|
| Related Party Transactions under Regulation 23(9) for the half year ended 31st March 2026 | Compliance under Regulation 23 (9) | |
| Related Party Transactions under Regulation 23(9) for the half year ended 30th September 2025 | Compliance under Regulation 23 (9) | |
| Related Party Transactions under Regulation 23(9) for the half year ended 31st March, 2025 | Compliance under Regulation 23 (9) | |
Rows per page:
1–1 of 1
1–1 of 1
▼ Compliance under Regulation 24(A)
| Title | Categories | Download |
|---|---|---|
| Annual Secretarial Compliance Report for the financial year ended 31st March, 2025 | Compliance under Regulation 24(A) | |
| Annual Secretarial Compliance Report for the financial year ended 31st March, 2026 | Compliance under Regulation 24(A) | |
Rows per page:
1–1 of 1
1–1 of 1
▼ Compliance under Regulation 27
| Title | Categories | Download |
|---|---|---|
| Compliance Report on Corporate Governance for the quarter and year ended 30th June 2026. | Compliance under Regulation 27 | |
| Compliance Report on Corporate Governance for the quarter and year ended 31st March 2026 | Compliance under Regulation 27 | |
| Compliance Report on Corporate Governance for the quarter ended 31st December 2025 | Compliance under Regulation 27 | |
| Compliance Report on Corporate Governance for the quarter and half year ended 30th September 2025 | Compliance under Regulation 27 | |
| Compliance Report on Corporate Governance for the quarter ended 30th June 2025 | Compliance under Regulation 27 | |
| Compliance Report on Corporate Governance for the quarter and year ended 31st March 2025 | Compliance under Regulation 27 | |
| Compliance Report on Corporate Governance for the quarter ended 31st December 2024 | Compliance under Regulation 27 | |
| Compliance Report on Corporate Governance for the quarter and half year ended 30th September, 2024 | Compliance under Regulation 27 | |
| Compliance Report on Corporate Governance for the quarter ended 30th June 2024 | Compliance under Regulation 27 | |
Rows per page:
1–2 of 2
1–2 of 2
▼ Compliance Under Regulation 50 (1)
| Title | Categories | Download |
|---|---|---|
| Intimation of Board Meeting dated 23rd April 2026 | Compliance under Regulation 50 (1) | |
| Intimation of Board Meeting dated 9th March 2026 | Compliance under Regulation 50 (1) | |
| Intimation of Board Meeting dated 12th January 2026 | Compliance Under Regulation 50 (1) | |
| Intimation of Board Meeting dated 10th October 2025 | Compliance Under Regulation 50 (1) | |
| Intimation of Board Meeting dated 23rd July 2025 | Compliance Under Regulation 50 (1) | |
| Update on agenda of Board Meeting to be held on Monday, the 14th day of July 2025 | Compliance Under Regulation 50 (1) | |
| Postponement of Board Meeting scheduled on Thursday, the 10th day of July 2025 to Monday, the 14th day of July 2025 | Compliance Under Regulation 50 (1) | |
| Intimation of Board Meeting dated 10th July 2025 | Compliance Under Regulation 50 (1) | |
| Intimation of Board Meeting dated 23 April 2025 | Compliance Under Regulation 50 (1) | |
| Intimation of Board Meeting dated 7 January 2025 | Compliance Under Regulation 50 (1) | |
| Intimation of Board Meeting dated 23 October 2024 | Compliance Under Regulation 50 (1) | |
| Intimation of Board Meeting dated 17 July 2024 | Compliance Under Regulation 50 (1) | |
| Intimation of Board Meeting dated 22 May 2024 | Compliance Under Regulation 50 (1) | |
Rows per page:
1-1 of 1
1-1 of 1
▼ Compliance Under Regulation 51
| Title | Categories | Download |
|---|---|---|
| Intimation of proceedings of the 3rd Annual General Meeting of Aquapharm Chemical Limited (formerly known as Advaya Chemical Industries Limited). | Compliance under Regulation 51 | |
| Intimation of proceedings of the 01/2026-27 Extra-Ordinary General Meeting of Aquapharm Chemical Limited (formerly known as Advaya Chemical Industries Limited). | Compliance under Regulation 51 | |
| Intimation of Newspaper Publication of Extract of Audited Consolidated Financial Results of the Company for the quarter and year ended 31st March 2026. | Compliance under Regulation 51 | |
| Intimation of Newspaper Publication of Extract of Un-Audited Consolidated Financial Results of the Company for the quarter ended 31st December 2025. | Compliance under Regulation 51 | |
| Intimation of Newspaper Publication of Extract of Un-audited Consolidated Financial Results of the Company for the quarter and half-year ended 30th September 2025. | Compliance under Regulation 51 | |
| Submission of details of listed ISIN of Aquapharm Chemical Limited for the half year ended 30th September 2025 – Half Yearly Reporting as per Chapter VIII of the SEBI Master Circular dated 22nd May 2024 | Compliance under Regulation 51 | |
| Intimation of appointment of Dr. Somil Mehta has been appointed as the Senior Vice President – Global R & D and Head, Innovation Centre of the Company. | Compliance under Regulation 51 | |
| Intimation of Newspaper Publication of Extract of Audited Consolidated Financial Results of the Company for the quarter and financial year ended 31st March 2025. | Compliance under Regulation 51 | |
| Submission of details of listed ISIN of Aquapharm Chemical Limited for the half year ended 31st March 2025 – Half Yearly Reporting as per Chapter VIII of the SEBI Master Circular dated 22nd May 2024 | Compliance under Regulation 51 | |
| Intimation under Regulation 51 read with Part B of Schedule III of SEBI Listing Regulations – Appointment of Mr. Suresh Kalra as an Additional Director and Whole-time Director, Mr. Kaushik Roy, as an Additional Director and cessation of Mr. Kaushik Mukherjee, as a Whole-time Director & Mr. Raj Kumar Gupta, as a Director | Compliance under Regulation 51 | |
| Intimation of the 2nd EGM Notice of Aquapharm Chemical Limited (formerly known as Advaya Chemical Industries Limited) relating to Appointment of Ms. Iram Hassan as a Director (Non-Executive Independent Director) and Mr. Gopal Rathi (DIN: 00553066) as a Director (Non-Executive Director) of the Company | Compliance under Regulation 51 | |
| Intimation under Regulation 51 read with Part B of Schedule III of SEBI Listing Regulations – Appointment of Mr. Suresh Kalra, as the Chief Executive Officer, KMP of the Company. | Compliance under Regulation 51 | |
| Intimation under Regulation 51 read with Part B of Schedule III of SEBI Listing Regulations – Allotment of equity shares of Advaya Chemical Industries Limited (subsidiary of PCBL Chemical Limited) pursuant to conversion of unlisted optionally and fully convertible debentures | Compliance under Regulation 51 | |
| Intimation under Regulation 51 read with Part B of Schedule III of SEBI Listing Regulations – Resignation of CS and CFO (KMPs) and Appointment of CS and CFO in place of resigning KMPs. | Compliance under Regulation 51 | |
| Intimation of the Newspaper Publication of the Extract of Unaudited Consolidated Financial Results for the quarter and nine months ended 31st December, 2024 | Compliance under Regulation 51 | |
| Intimation under Regulation 51(2) of the SEBI Listing Regulations read with Part B of Schedule III – Appointment of Mr. Gopal Rathi and Ms. Iram Hassan | Compliance under Regulation 51 | |
| Disclosures under Regulation 51 for Scheme of Amalgamation of Aquapharm Chemicals Private Limited with the Company | Compliance under Regulation 51 | |
| Appt of IDs, Cessation of GR and Shifting of RO | Compliance under Regulation 51 | |
| Fine levied under Reg 6 | Compliance under Regulation 51 | |
| Fine levied under Reg 6 (Reply) | Compliance under Regulation 51 | |
| Appt of CS | Compliance under Regulation 51 | |
| Appt of CFO & WTD | Compliance under Regulation 51 | |
| Submission of details of listed ISIN of Advaya Chemical Industries Limited for the half year ended 30th September, 2024 – Half Yearly Reporting as per Chapter VIII of the SEBI Master Circular dated 22nd May, 2024 | Compliance under Regulation 51 | |
| Intimation of the 1st EGM Notice of Advaya Chemical Industries Limited relating to approval of the scheme of amalgamation of Aquapharm Chemicals Private Limited with Advaya Chemical Industries Limited and their respective shareholders | Compliance under Regulation 51 | |
| Intimation of proceedings of the 1st EGM of Advaya Chemical Industries Limited | Compliance under Regulation 51 | |
| Intimation of Newspaper Publication of the Extract of Unaudited Consolidated Financial Results for the quarter and half year ended 30th September, 2024 | Compliance under Regulation 51 | |
| Intimation pursuant to Regulation 51 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015 (“SEBI Listing Regulations”) read with Part B of Schedule III of SEBI Listing Regulations – Change in Auditor (Resignation of Statutory Auditor) | Compliance under Regulation 51 | |
Rows per page:
1–5 of 22
1–5 of 22
▼ Compliance under Regulations 52
| Title | Categories | Download |
|---|---|---|
| Financial Results (Standalone & Consolidated) for the quarter and year ended 30th June 2026 | Compliance under Regulations 52 | |
| Financial Results (Standalone & Consolidated) for the quarter and year ended 31st March 2026 | Compliance under Regulations 52 | |
| Financial Results (Standalone & Consolidated) for the quarter ended 31st December 2025 | Compliance under Regulations 52 | |
| Financial Results for the quarter and half-year ended 30th September 2025 | Compliance under Regulations 52 | |
| Financial Results for the quarter and year ended 31st March 2025 | Compliance under Regulations 52 | |
| Financial Results for the quarter and nine months ended 31st December, 2024 | Compliance under Regulations 52 | |
| Financials (30-09-2024) | Compliance under Regulations 52 | |
| Financials (30-06-2024) | Compliance under Regulations 52 | |
| Statement of Utilization of Issue Proceeds of NCD | Compliance under Regulations 52 | |
| Financials (31-03-2024) | Compliance under Regulations 52 | |
Rows per page:
1-6 of 6
1-6 of 6
▼Compliance under Regulation 53
| Title | Categories | Download |
|---|---|---|
| Annual Report – FY 2025-26 | Compliance under Regulation 53 | |
| Annual Report – FY 2024-25 | Compliance under Regulation 53 | |
| Annual Report – FY 2023-24 | Compliance under Regulation 53 | |
| Financial Statements of Aquapharm Chemicals Private Limited | Compliance under Regulation 53 | |
| Draft Annual Return in Form MGT-7 for the FY 23-24 | Compliance under Regulation 53 | |
| Submission of the summary of the Proceedings of the 1st Annual General Meeting of the Members of the Company | Compliance under Regulation 53 | |
| Newspaper Advertisement – Publication of the Notice of the 1st Annual General Meeting and Book Closure Notice for the financial year ended 31st March, 2024 | Compliance under Regulation 53 | |
| Financial Statements of Aquapharm Chemical Limited (formerly known as Advaya Chemical Industries Limited) | Compliance under Regulation 53 | |
| Draft Annual Return in Form MGT-7 for the FY 25-26 | Compliance under Regulation 53 | |
| Draft Annual Return in Form MGT-7 for the FY 24-25 | Compliance under Regulation 53 | |
| Submission of the summary of the Proceedings of the 1st Annual General Meeting of the Members of the Company | Compliance under Regulation 53 | |
Rows per page:
1–5 of 5
1–5 of 5
▼ Compliance under Regulations 54
Asset Cover Details (31-03-2024)Compliance under Regulations 54
| Title | Categories | Download |
|---|---|---|
| Asset Cover Details (30-06-2026) | Compliance under Regulations 54 | |
| Asset Cover Details (31-03-2026) | Compliance under Regulations 54 | |
| Asset Cover Details (31-12-2025) | Compliance under Regulations 54 | |
| Asset Cover Details (30-09-2025) | Compliance under Regulations 54 | |
| Asset Cover Details (30-06-2025) | Compliance under Regulations 54 | |
| Asset Cover Details (31-03-2025) | Compliance under Regulations 54 | |
| Asset Cover Details (31-12-2024) | Compliance under Regulations 54 | |
| Asset Cover Details (30-09-2024) | Compliance under Regulations 54 | |
| Asset Cover Details (30-06-2024) | Compliance under Regulations 54 | |
Rows per page:
1–3 of 3
1–3 of 3
▼Compliance under Regulations 55
| Title | Categories | Download |
|---|---|---|
| Credit Rating – Non-Convertible Debentures (NCDs) – 9th January 2026 | Compliance under Regulations 55 | |
| Credit Rating – Bank Facilities – 9th January 2026 | Compliance under Regulations 55 | |
| Credit Rating – Non-Convertible Debentures (NCDs) – 3rd March 2025 | Compliance under Regulations 55 | |
| Credit Rating – Bank Facilities – 3rd March 2025 | Compliance under Regulations 55 | |
| Credit Rating – Non-Convertible Debentures (NCDs) – 15 January 2024 | Compliance under Regulations 55 | |
| Credit Rating – Bank Facilities – 15 January 2024 | Compliance under Regulations 55 | |
Rows per page:
1–3 of 3
1–3 of 3
▼Compliance under Regulation 57
| Title | Categories | Download |
|---|---|---|
| Intimation of annual interest payment under Regulation 57 of the SEBI Listing Regulations – Advaya – 2025 | Compliance under Regulation 57 | |
| Intimation of annual interest payment under Regulation 57 of the SEBI Listing Regulations – ACL – 2026 | Compliance under Regulation 57 | |
Rows per page:
1–1 of 1
1–1 of 1
▼Compliance under Regulation 59A
| Title | Categories | Download |
|---|---|---|
| Amalgamation Notice | Compliance under Regulation 59A | |
Rows per page:
1–1 of 1
1–1 of 1
▼ Compliance under Regulation 61(4)
No documents available under Regulation 61(4) currently.
General Meetings
General Meetings
AGM – 2025
Recording of the proceedings of the AGM:
| Title | Categories | Download |
|---|---|---|
| Aquapharm Chemical Limited – Annual Report 2024-25 | AGM – 2025 , General Meeting | |
EGM – 29.06.2026
| Title | Categories | Download |
|---|---|---|
| Shorter Notice of the 01/2026-27 Extra Ordinary General Meeting – Monday, 29th June 2026 | EGM – 29.06.2026 | |
AGM – 2026
| Title | Categories | Download |
|---|---|---|
| Aquapharm Chemical Limited – Annual Report 2025-26 | AGM – 2026 , General Meeting | |
